[
  {
    "ts": null,
    "headline": "Top Dividend Stocks To Consider In September 2025",
    "summary": "As major U.S. indices hit record highs, driven by a surge in technology stocks and strategic investments, the market continues to present intriguing opportunities for investors. In this dynamic environment, dividend stocks remain an attractive option for those seeking steady income and potential growth amid fluctuating interest rates and evolving economic conditions.",
    "url": "https://finnhub.io/api/news?id=241555acccac7a4f7d3aac9a451d5798422a701e5c16f1acba58711ee2d714f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758220354,
      "headline": "Top Dividend Stocks To Consider In September 2025",
      "id": 136801191,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "As major U.S. indices hit record highs, driven by a surge in technology stocks and strategic investments, the market continues to present intriguing opportunities for investors. In this dynamic environment, dividend stocks remain an attractive option for those seeking steady income and potential growth amid fluctuating interest rates and evolving economic conditions.",
      "url": "https://finnhub.io/api/news?id=241555acccac7a4f7d3aac9a451d5798422a701e5c16f1acba58711ee2d714f2"
    }
  },
  {
    "ts": null,
    "headline": "Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case",
    "summary": "Nanobiotix S.A. stock surges on promising cancer trial results and major partnership. Click for more on NBTX stock and why I'm bullish on this microcap.",
    "url": "https://finnhub.io/api/news?id=bee0716893cf81327a107421f4275d560f911df23c42a3c77dbe0d7f6be4a128",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758203790,
      "headline": "Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case",
      "id": 136800807,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1762540902/image_1762540902.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Nanobiotix S.A. stock surges on promising cancer trial results and major partnership. Click for more on NBTX stock and why I'm bullish on this microcap.",
      "url": "https://finnhub.io/api/news?id=bee0716893cf81327a107421f4275d560f911df23c42a3c77dbe0d7f6be4a128"
    }
  },
  {
    "ts": null,
    "headline": "It Is Time To Buy Novo Nordisk Hand Over Fist",
    "summary": "Novo Nordisk A/S is a strong buy for 2024, with cutting-edge drug approvals, cost savings, and robust long-term growth potential. Click for my NVO stock update.",
    "url": "https://finnhub.io/api/news?id=f26d7f9d18be7c9d325c14942cd167cc0a9c060fce57599bb030fe95427afe83",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758188162,
      "headline": "It Is Time To Buy Novo Nordisk Hand Over Fist",
      "id": 136798863,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2153927815/image_2153927815.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk A/S is a strong buy for 2024, with cutting-edge drug approvals, cost savings, and robust long-term growth potential. Click for my NVO stock update.",
      "url": "https://finnhub.io/api/news?id=f26d7f9d18be7c9d325c14942cd167cc0a9c060fce57599bb030fe95427afe83"
    }
  }
]